Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

Significant Accounting Policies (Tables)

v3.22.1
Significant Accounting Policies (Tables)
12 Months Ended
Dec. 31, 2021
Accounting Policies [Abstract]  
Schedule of property, plant and equipment
    %     Mainly
%
 
             
Laboratory equipment and Leasehold improvements     10       10  
                 
Computers, office furniture and equipment     6 - 33       33  

 

Schedule of major customer data as a percentage of total revenues
    December 31,  
    2021     2020  
             
Cipher Pharmaceuticals     12 %     20 %
Chong Kun Dang Pharmaceuticals Corp.     24 %     45 %
Gebro Holding GmBH     23 %     35 %
Ewopharma AG     41 %    
-
 
                 
      100 %     100 %